OrbiMed colleague Neev Mistry received the recent acceptance of his reproducibility study by Transactions on Machine Learning Research (TMLR) on computationally efficient methods that help explain why machine learning models make specific predictions.

OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies. OrbiMed’s team of over 100 professionals is based in New York City, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya, and other key global markets.